TIEG1-null osteocytes display defects in their morphology, density and surrounding bone matrix

Journal of Musculoskeletal Research

Volumn 12, Issue 3, 2009, Pages 127-136

  Haddad, Oualid ^a   Hawse, John R ^b   Subramaniam, Malayannan ^b   Spelsberg, Thomas C ^b   Bensamoun, Sabine F ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^b MAYO CLINIC   (United States)

Author keywords

Bone remodeling; Cell morphology; Osteocyte; Transmission Electron Microscopy

Indexed keywords

TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 1; UNCLASSIFIED DRUG;

AGE; AGED; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MATRIX; BONE MINERALIZATION; BONE REMODELING; CELL COMMUNICATION; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

EID: 76449122151     PISSN: 02189577     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218957709002304     Document Type: Article

References (37)

1. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C,WuytsWet al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mole Genet 10: 537-543, 2001.
2. Baylink DJ, Wergedal JE. Bone formation by osteocytes. Am J Physiol 221: 669-678, 1971.
3. Bensamoun SF, Hawse JR, Subramaniam M, Ilharreborde B, Bassillais A, Benhamou CL, Fraser DG, Oursler MJ, Amadio PC, An KN, Spelsberg TC. TGF inducible early gene-1 knockout mice display defects in bone strength and microarchitecture. Bone 39: 1244-1251, 2006.
4. Bensamoun SF, Tsubone T, Subramaniam M, Hawse JR, Boumediene E, Spelsberg TC, An KN, Amadio PC. Agedependent changes in the mechanical properties of tail tendons in TGF-beta inducible early gene-1 knockout mice. J Appl Physio 101(5): 1419-1424, 2006.
5. Bonewald LF. Mechanosensation and transduction in osteocytes. Bonekey Osteovision 3: 7-15, 2006.
6. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68: 577-589, 2001.
7. Cowin SC, Weinbaum S, Zeng Y. A case for bone canaliculi as the anatomic site of strain generated potentials. J Biomech 28: 1281-1297, 1995.
8. Duncan RL, Misler S. Voltage-activated and stretchactivated Ba21 conducting channels in an osteoblast-like cell line (UMR-106). Fed Eur Bone Soc Lett 251: 17-21,1989.
9. Feng JQ,Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38: 1310-1315, 2006.
10. Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, Heillman M, Derynck R. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126: 4267-4279, 1999.
11. Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone 23: 87-93, 1998.
12. Harrigan TP, Hamilton JJ. Bone strain sensation via transmembrane potential changes in surface osteoblasts: Loading rate and microstructural implications. J Biomech 26: 183-200, 1993.
13. Hawse JR, Iwaniec UT, Bensamoun SF, Monroe DG, Peters KD, Ilharreborde B, Rajamannan NM, Oursler MJ, Turner RT, Spelsberg TC, Subramaniam M. TIEG-null mice display an osteopenic gender-specific phenotype. Bone 42: 1025-1031, 2008.
14. Irie K, Ejiri S, Sakakura Y, Shibui T, Yajima T. Matrix mineralization as a trigger for osteocyte maturation. J Histochem Cytochem 56: 561-567, 2008.
15. Johnsen SA, Subramaniam M, Janknecht R, Spelsberg TC. TGFbeta inducible early gene enhances TGFbeta/Smaddependent transcriptional responses. Oncogene 21: 5783-5790, 2002.
16. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110: 2195-2207, 1990.
17. Klein-Nulend J, Semeins CM, Ajubi NE, Nijweide PJ, Burger EH. Pulsating fluid flow increases nitric oxyde (NO) synthesis by osteocytes but not periosteal fibroblasts-correlation with prostaglandin upregulation. Biochem Biophys Res Commun 217: 640-648, 1995.
18. Klein-Nulend J, van der Plas A, Semeins CM, Ajubi NE, Frangos JA, Nijweide PJ, Burger EH. Sensitivity of osteocytes to biomechanical stress in vitro. FASEB J 9: 441-445, 1995.
19. Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF. Glucocorticoidtreated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 1: 466-476, 2006.
20. Martin RB.Towarda unifying theory of bone remodeling. Bone 26: 1-6, 2000.
21. Marotti G. The osteocyte as a wiring transmission system. J Musculoskel Neuron Interact 1: 133-136, 2000.
22. McCreadie BR, Hollister SJ, Schaffler MB, Goldstein SA. Osteocyte lacuna size and shape in women with and without osteoporotic fracture. J Biomech 37: 563-572, 2004.
23. Poole KES, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, Reeve J. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 19: 1842-1844, 2005.
24. Rubin MA, Jasiuk I. The TEM characterization of the lamellar structure of osteoporotic human trabecular bone. Micron 36: 653-664, 2005.
25. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 23: 4907-4912, 1995.
26. Subramaniam M, Hefferan TE, Tau K, Peus D, Pittelkow M, Jalal S, Riggs BL, Roche P, Spelsberg TC. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J Cell Biochem 68: 226-236, 1998.
27. Subramaniam M, Gorny G, Johnsen SA, Monroe DG, Evans GL, Fraser DG, RickardDJ et al. TIEG1 null mousederived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol 25: 1191-1199, 2005.
28. Sutherland MK, Geoghegan JC, Yu C, Turcott E, Skonier JE, Winkler DG, Latham JA. Sclerostin promotes the apoptosis of human osteoblastic cells:Anovel regulation of bone formation. Bone 35: 828-835, 2004.
29. Tachibana I, Imoto M, Adjei PN, Gores GJ, Subramaniam M, Spelsberg TC and Urrutia R. Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 99: 2365-2374, 1997.
30. van Bezooijen RL, Roelen BA, Visser A, van derWee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE, ten Dijke P, Lowik CW. Sclerostin is an osteocyteexpressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199: 805-814, 2004.
31. van Bezooijen RL, Svensson JP, Eefting D, Visser A, van der Horst G, Karperien M et al. Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Mineral Res 22: 19-28, 2007.
32. Vashishth D, Verborgt O, Divine G, Schaffler MB and Fyhrie DP. Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age. Bone 26: 375-380, 2000.
33. Vatsa A, Breuls RG, Semeins CM, Salmon PL, Smit TH, Klein-Nulend J. Osteocyte morphology in fibula and calvaria-is there a role for mechanosensing? Bone 43: 452-458, 2008.
34. Wang Z, Peters B, Klussmann S, Bender H, Herb A, Krieglstein K. Gene structure and evolution of Tieg3, a new member of the Tieg family of proteins. Gene 325: 25-34, 2004.
35. Weinbaum S, Cowin SC, Zeng Y. A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech 27: 339-360, 1994.
36. Winkler DG, Sutherland MK, Geoghegan JC,Yu C, Hayes T, Skonier JE, Shpektor D et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22: 6267-6276, 2003.
37. You LD, Weinbaum S, Cowin SC, Schaffler MB. Ultrastructure of the osteocyte process and its pericellular matrix. Anat Rec 278A: 505-513, 2004.